[HTML][HTML] FDG-PET imaging in the management of non-small-cell lung cancer
E Salminen, M Mac Manus - Annals of oncology, 2002 - Elsevier
Lung cancer is currently the leading cause of cancer-related death in both men and women
in most Western countries. Tumour stage is the strongest prognostic factor and the most …
in most Western countries. Tumour stage is the strongest prognostic factor and the most …
Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer
E Salminen, MM Manus - Annals of medicine, 2001 - Taylor & Francis
Lung cancer is currently the leading cause of cancer-related death in both men and women
in most Western countries. Although 5-year survival rates have doubled from 1960s they are …
in most Western countries. Although 5-year survival rates have doubled from 1960s they are …
Value of FDG-PET in the management of non-small cell lung cancer
S Stroobants, J Verschakelen… - European journal of …, 2003 - Elsevier
In the past 5 years, metabolic imaging with positron emission tomography (PET) using 18F-
fluoro-2-deoxy-glucose (FDG) has become an important imaging modality in lung cancer …
fluoro-2-deoxy-glucose (FDG) has become an important imaging modality in lung cancer …
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
JF Vansteenkiste, SG Stroobants - European Respiratory …, 2001 - Eur Respiratory Soc
In the past 5 yrs, positron emission tomography (PET) with 18F-fluoro-2-deoxy-d-glucose
(FDG) has become an important imaging modality in lung cancer patients. At this time, the …
(FDG) has become an important imaging modality in lung cancer patients. At this time, the …
FDG-PET/CT in lung cancer: an update
The prognosis of lung cancer patients mostly depends on the stage at which the disease is
diagnosed. Contrast-enhanced CT (ceCT) and MRI play a significant role in initial staging …
diagnosed. Contrast-enhanced CT (ceCT) and MRI play a significant role in initial staging …
Positron emission tomography imaging in lung cancer
EF Patz Jr, JJ Erasmus - Clinical Lung Cancer, 1999 - Elsevier
Over the past several years, positron emission tomography (PET) has become a clinically
useful, noninvasive study which complements conventional imaging (chest radiographs …
useful, noninvasive study which complements conventional imaging (chest radiographs …
Prognosis and reevaluation of lung cancer by positron emission tomography imaging
JJ Erasmus, E Rohren, SG Swisher - Proceedings of the American …, 2009 - atsjournals.org
Positron emission tomography (PET) imaging using 18F-2-deoxy-D-glucose, a D-glucose
analog labeled with fluorine-18 (FDG-PET), is being evaluated in the assessment of …
analog labeled with fluorine-18 (FDG-PET), is being evaluated in the assessment of …
Lung cancer and positron emission tomography with fluorodeoxyglucose
EM Marom, JJ Erasmus, EF Patz Jr - Lung Cancer, 2000 - Elsevier
Over the past years, positron emission tomography (PET) with fluoro-2-deoxy-d-glucose
(FDG) has emerged as an important imaging modality. In the thorax, FDG-PET has been …
(FDG) has emerged as an important imaging modality. In the thorax, FDG-PET has been …
Value of FDG PET in the management of NSCLC
D Ukena, D Hellwig - Lung cancer, 2004 - Elsevier
Metabolic imaging with positron emission tomography (PET) using 18F-fluoro-2-deoxy-
glucose (FDG) has been accepted as an important imaging modality in lung cancer. FDG …
glucose (FDG) has been accepted as an important imaging modality in lung cancer. FDG …
State-of-the-art FDG-PET imaging of lung cancer
MD Gilman, SL Aquino - Seminars in Roentgenology, 2005 - Elsevier
The d-glucose analog 2-(fluorine-18)-fluoro-2-deoxy-d-glucose (FDG) is the most commonly
used radionuclide in positron emission tomography (PET) of lung cancer. FDG-PET is a …
used radionuclide in positron emission tomography (PET) of lung cancer. FDG-PET is a …